p. 233−272
2090-7125
Vol.28/No.1
7g/dl). The prevalence of anemia in mother’s is > 47 %, which represent a problem of high degree, while, the prevalence of anemia in sibling is 52.25 & 54.03 % for male and female respectively which represent a problem of high degree. The cause of anemia in mothers may be due to menstrual blood loss, increased duration of menstrual blood flow, while in children may be due to anemic mother, poor, diet, bad food habit.
Conclusion: To reduce prevalence of anemia and improve anemic mothers, sibling status in Egypt we needs to improve iron supplementation program ]]>
p. 295−305
2090-7125
Vol.28/No.1
p. 327−341
2090-7125
Vol.28/No.1
p. 342−346
2090-7125
Vol.28/No.1
p. 347−354
2090-7125
Vol.28/No.1
p. 355−362
2090-7125
Vol.28/No.1
p. 363−370
2090-7125
Vol.28/No.1
p. 397−403
2090-7125
Vol.28/No.1
p. 404−417
2090-7125
Vol.28/No.1
0.05).
Conclusion: Our study provides evidence of Her-2/neu overexpression in a considerable proportion of the patients with uterine adenocarcinoma, thus suggesting the opportunity for the possible use of anti-Her-2/neu therapy in this malignancy by selective inhibition of Her-2/neu. The use of Herceptin, a monoclonal antibody directed against Her-2/neu, for therapy of patients harboring Her-2/neu positive EC may be beneficial. Her-2/neu overexpression is related to most of the prognostic variables of EC and may be incorporated into the criteria for determination of tumor aggressiveness as a prognostic marker. ]]>
p. 418−428
2090-7125
Vol.28/No.1
p. 429−438
2090-7125
Vol.28/No.1
p. 439−447
2090-7125
Vol.28/No.1